erlotinib has been researched along with gw8510 in 2 studies
Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (gw8510) | Trials (gw8510) | Recent Studies (post-2010) (gw8510) |
---|---|---|---|---|---|
221 | 0 | 180 | 25 | 0 | 16 |
Protein | Taxonomy | erlotinib (IC50) | gw8510 (IC50) |
---|---|---|---|
Cyclin-T1 | Homo sapiens (human) | 0.54 | |
High affinity nerve growth factor receptor | Homo sapiens (human) | 0.009 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.0745 | |
Cyclin-dependent kinase 4 | Homo sapiens (human) | 0.139 | |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 0.049 | |
Cyclin-A2 | Homo sapiens (human) | 0.0065 | |
G1/S-specific cyclin-D1 | Homo sapiens (human) | 0.139 | |
G1/S-specific cyclin-E1 | Homo sapiens (human) | 0.003 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.0079 | |
Cyclin-dependent kinase 7 | Homo sapiens (human) | 0.317 | |
Cyclin-dependent kinase 9 | Homo sapiens (human) | 0.54 | |
Cyclin-H | Homo sapiens (human) | 0.317 | |
CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | 0.317 | |
Cyclin-A1 | Homo sapiens (human) | 0.01 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.007 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.007 | |
Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB | 1 |
Balke-Want, H; Basu, D; Engel, J; Ercanoglu, MS; Rauh, D; Richters, A; Tesch, R; Thomas, RK | 1 |
2 other study(ies) available for erlotinib and gw8510
Article | Year |
---|---|
Navigating the kinome.
Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology | 2011 |
Identification and further development of potent TBK1 inhibitors.
Topics: Animals; Cell Line; Drug Design; Humans; Macrophages; Mice; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Small Molecule Libraries; Structure-Activity Relationship | 2015 |